Categories: Technology

Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them

Company announcement no. 32

In accordance with Article 19 (3) of the Market Abuse Regulation, Columbus A/S is required to disclose information regarding trading in Columbus A/S shares and/or related securities by persons discharging managerial responsibilities in Columbus A/S and/or persons closely associated with them.

Please see the attached documents for transaction details reported to Columbus.

Ib Kunøe                                      Søren Krogh Knudsen
Chairman of the Board                CEO & President

For further information, please contact:
CEO & President, Søren Krogh Knudsen, +45 70 20 50 00

GlobeNews Wire

Share
Published by
GlobeNews Wire
Tags: a/s:andassociatedcloselycolumbusCopenhagen:COLUMdischargingDK0010268366managerialnewsnotificationpersonsrelatedresponsibilitiessecuritiessharesthemtransactionswith
6 months ago

Recent Posts

Blockchain.com Unveils Highly Anticipated Crypto-Backed Loans, Bringing Borrowing To Crypto Holders Worldwide

The company launches in-house lending for global users starting at 1.9%, delivering one of the…

7 hours ago

Artmarket.com: The Artprice Manifesto: 22 Rules for a Regulated and Transparent Art Market in the Age of AI

Artificial intelligence is redistributing the value of information at an unprecedented pacePARIS, May 14, 2026…

7 hours ago

Crypto News: AlphaPepe Presale Records Surge in Whale Accumulation As Bitcoin Price Prediction Eyes $180,000

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…

16 hours ago

Crypto Market News: AlphaPepe Finalizes Tier-1 Exchange Shortlist as XRP Price Prediction Targets $5.00

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto market news is turning toward AlphaPepe after…

16 hours ago

Qoder Version 1.0 Released: Full Automation of Code Generation, Verification & Delivery

SINGAPORE, May 16, 2026 (GLOBE NEWSWIRE) -- Qoder officially releases version 1.0, upgrading from an…

16 hours ago

Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction

Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically…

16 hours ago